SEP 10, 2026 · PHASE 1 TRIAL
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
ClinicalTrials.gov
This is a Phase 1 study registration with no posted results; it is designed to establish safety and maximum tolerated dose in a small population, representing early-stage clinical evaluation.
Reported
Estimated enrollment60
PhasePhase 1
Primary outcome measureIncidence of Dose-Limiting Toxicities as As…